NAMS MENOPAUSE
CERTIFICATION EXAM
2025-2026 WITH
CORRECT ANSWERS NAMS MENOPAUSE
GRADED A+
The NAMS Menopause Certification Exam 2025–2026 Guide delivers a
clear, practical, and engaging overview of the essential knowledge
clinicians need to excel in menopause care. Grounded in current
evidence and best-practice recommendations, this resource simplifies
complex hormonal concepts, highlights key diagnostic and treatment
principles, and strengthens clinical decision-making skills. Designed to
boost confidence and mastery, it equips learners with structured review
insights to support success on the NAMS certification exam and enhance
the quality of care provided to midlife and menopausal patients.
,NAMS MENOPAUSE CERTIFICATION EXAM
2025-2026 WITH CORRECT ANSWERS
,Climacteric phase ANSWER >> The period of endocrinologic, somatic, and transitory
psychologic changes that occur around the time of menopause.
Early menopause ANSWER >> LMP before age 45.
Late menopause ANSWER >> LMP after age 54.
Primary ovarian insufficiency ANSWER >> Menopause that occurs before age 40.
Early menopause transition (stage -2) ANSWER >> Persistent difference of 7 days or more in
the length of consecutive cycles.
Late menopause transition (stage -1) ANSWER >> 60 or more consecutive days of
amenorrhea.
Luteal out of phase event (LOOP) ANSWER >> Explains why some perimenopausal women
have elevated estrogen levels sometimes.
Obese women and estradiol levels during menopause ANSWER >> Obese women are more
likely to have anovulatory cycles with high estradiol levels.
Chinese and Japanese women ANSWER >> These ethnic groups have lower estradiol levels
than white, black, and Hispanic women.
Stage +2 ANSWER >> Late menopause stage: 5-8 years after FMP. Somatic aging
predominates.
Stages +1a, +1b, +1c ANSWER >> Early post menopause: 2 years after FMP. FSH rises,
estradiol decreases.
Elevated FSH, LH ANSWER >> Endocrine labs after menopause.
, AMH, inhibin B ANSWER >> These hormones work during reproductive years to not deplete
follicle pool too quickly.
Phases during menopause transition and PMS symptoms ANSWER >> Menstrual cycle
variable, persistent >7 day difference between difference in length of consecutive cycles.
How to respond if a patient requests FSH lab? ANSWER >> Many pitfalls, variable
depending on the day of the cycle you draw the lab.
The potentially superior marker of menopause, a lab. ANSWER >> AMH.
DHEA (dehydroepiandrosterone) ANSWER >> Adrenal androgens: precursor hormones
produced by the adrenal gland that are enzymatically converted to active androgens or
estrogens in peripheral tissues.
Location of estrogen receptors ANSWER >> Vagina, vulva, urethra, trigone of the bladder.
Effects of estrogen on tissue ANSWER >> Maintain blood flow, the collagen, and HA within
the epithelial surfaces.
Vaginal changes with menopause ANSWER >> Thinning, loss of elasticity, loss or absence
of rugae.
Vagina and urethra in menopause ANSWER >> Vagina narrows, urethra moves closer to the
introitus.
Stress urinary incontinence ANSWER >> Vaginal estrogen and urinary incontinence: what
type does it help with?
Treatment for FPHL ANSWER >> Minoxidil, spironolactone, finasteride, estrogen therapy.
Late reproductive years -3b and -3a ANSWER >> -3b: menstrual cycles normal, FSH normal,
AMH low, AFC low, inhibin low. -3a: subtle menstrual changes, variable FSH, AMH low, AFC
low, inhibin low.
CERTIFICATION EXAM
2025-2026 WITH
CORRECT ANSWERS NAMS MENOPAUSE
GRADED A+
The NAMS Menopause Certification Exam 2025–2026 Guide delivers a
clear, practical, and engaging overview of the essential knowledge
clinicians need to excel in menopause care. Grounded in current
evidence and best-practice recommendations, this resource simplifies
complex hormonal concepts, highlights key diagnostic and treatment
principles, and strengthens clinical decision-making skills. Designed to
boost confidence and mastery, it equips learners with structured review
insights to support success on the NAMS certification exam and enhance
the quality of care provided to midlife and menopausal patients.
,NAMS MENOPAUSE CERTIFICATION EXAM
2025-2026 WITH CORRECT ANSWERS
,Climacteric phase ANSWER >> The period of endocrinologic, somatic, and transitory
psychologic changes that occur around the time of menopause.
Early menopause ANSWER >> LMP before age 45.
Late menopause ANSWER >> LMP after age 54.
Primary ovarian insufficiency ANSWER >> Menopause that occurs before age 40.
Early menopause transition (stage -2) ANSWER >> Persistent difference of 7 days or more in
the length of consecutive cycles.
Late menopause transition (stage -1) ANSWER >> 60 or more consecutive days of
amenorrhea.
Luteal out of phase event (LOOP) ANSWER >> Explains why some perimenopausal women
have elevated estrogen levels sometimes.
Obese women and estradiol levels during menopause ANSWER >> Obese women are more
likely to have anovulatory cycles with high estradiol levels.
Chinese and Japanese women ANSWER >> These ethnic groups have lower estradiol levels
than white, black, and Hispanic women.
Stage +2 ANSWER >> Late menopause stage: 5-8 years after FMP. Somatic aging
predominates.
Stages +1a, +1b, +1c ANSWER >> Early post menopause: 2 years after FMP. FSH rises,
estradiol decreases.
Elevated FSH, LH ANSWER >> Endocrine labs after menopause.
, AMH, inhibin B ANSWER >> These hormones work during reproductive years to not deplete
follicle pool too quickly.
Phases during menopause transition and PMS symptoms ANSWER >> Menstrual cycle
variable, persistent >7 day difference between difference in length of consecutive cycles.
How to respond if a patient requests FSH lab? ANSWER >> Many pitfalls, variable
depending on the day of the cycle you draw the lab.
The potentially superior marker of menopause, a lab. ANSWER >> AMH.
DHEA (dehydroepiandrosterone) ANSWER >> Adrenal androgens: precursor hormones
produced by the adrenal gland that are enzymatically converted to active androgens or
estrogens in peripheral tissues.
Location of estrogen receptors ANSWER >> Vagina, vulva, urethra, trigone of the bladder.
Effects of estrogen on tissue ANSWER >> Maintain blood flow, the collagen, and HA within
the epithelial surfaces.
Vaginal changes with menopause ANSWER >> Thinning, loss of elasticity, loss or absence
of rugae.
Vagina and urethra in menopause ANSWER >> Vagina narrows, urethra moves closer to the
introitus.
Stress urinary incontinence ANSWER >> Vaginal estrogen and urinary incontinence: what
type does it help with?
Treatment for FPHL ANSWER >> Minoxidil, spironolactone, finasteride, estrogen therapy.
Late reproductive years -3b and -3a ANSWER >> -3b: menstrual cycles normal, FSH normal,
AMH low, AFC low, inhibin low. -3a: subtle menstrual changes, variable FSH, AMH low, AFC
low, inhibin low.
